Key result
This review outlines the pathophysiology, diagnosis, and critical care management of congenital and acquired valvar cardiac disease in the paediatric population.
This review provides a comprehensive overview of the pathophysiology and critical care management of pediatric valvar heart disease.
May inform pediatric valvar disease management; leaves open need for prospective trials to strengthen recommendations.
Valvar cardiac disease accounts for a large percentage of heart lesions in the paediatric population. There are a variety of congenital and acquired valvar lesions produced by different mechanisms that produce unique physiologies. With the development of more advanced cardiac interventional procedures and congenital cardiac surgery techniques, most of these lesions can be repaired in a single or multi-stage approach. Given the potential for significant symptomatology before intervention, it is imperative to review the critical care management of paediatric valvar heart disease. The purpose of this article is to provide an overview of the current critical care management of valvar cardiac disease. We approach each cardiac valve individually in order to review the pathophysiology caused by valve dysfunction (obstruction and incompetence) and elaborate on the most frequent diagnoses, specific cardiac physiology, potential for other organ system associations, and perioperative management.
No takes yet. Share an insight, caveat, or question.
Moore et al. (2014) conducted a review in paediatric valvar cardiac disease. Critical care management was evaluated. This review outlines the pathophysiology, diagnosis, and critical care management of congenital and acquired valvar cardiac disease in the paediatric population.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: